It's official. The drug industry's chief lobbyists — the Pharmaceutical Research and Manufacturers of America — raised and spent at least $101.2 million in 2009 on advocacy efforts during the contentious health care overhaul debate, according to tax documents the group filed last month.
Former PhRMA CEO Billy Tauzin tells Shots the lobby used the money — special contributions from member companies — for broadcast and print ads, grassroots and direct lobbying, polling and consulting. Tauzin, who has a two-year contract to advise PhRMA's new leader, recently opened his own DC-based lobbying shop with his son Tom.
Political Glance
A majority of Americans want the Congress to keep the new health care law or actually expand it, despite Republican claims that they have a mandate from the people to kill it, according to a new McClatchy-Marist poll.
A federal jury Monday convicted Washington lobbyist Kevin A. Ring on five of eight counts related to the Jack Abramoff bribery and influence-peddling scandal, handing a victory to the Justice Department unit charged with fighting corruption in government.





























